Treatment of Ductal Carcinoma in Situ of the Breast: Review of Recent Advances and Future Prospects

International Journal of Fertility and Women's Medicine

Volumn 48, Issue 5, 2003, Pages 217-225

  Mokbel, Kefah ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

DCIS; Mastectomy; Radiotherapy; Reconstruction; Tamoxifen; Treatment

Indexed keywords

ACOLBIFENE; ANASTROZOLE; AROMATASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FULVESTRANT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST RECONSTRUCTION; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOSCOPY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; LASER SURGERY; MALIGNANT TRANSFORMATION; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; MYOCUTANEOUS FLAP; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 0242720216     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Shoker BS, Sloane JP: DCIS grading schemes and clinical implications Review. Histopathology 35:393-400, 1999.
2. Page DL, Dupont WD, Rogers LW, et al: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated by biopsy. Cancer 76:1197-1200, 1995.
3. Welch HG, Black WC: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 127:1023-1028, 1997.
4. Ernster VL, Barclay J, Kerlikowske K, et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918, 1996.
5. Moss SM, Michel M, Patnick J, et al: Results from the NHS breast screening programme 1990-1993. J Med Screen 2:186-190, 1995.
6. Verkooijen HM, Core Biopsy After Radiological Localisation (COBRA) Study Group: Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 99:853-859, 2002.
7. Dahlstrom JE, Jain S: Histological correlation of mammographically detected microcalcifications in stereotactic core biopsies. Pathology 33:444-448, 2001.
8. Fischer U, Baum F, Obenauer S, et al: Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol 12:2679-2683, 2002.
9. Bazzocchi M, Facecchia I, Zuiani C, et al: Application of a computer-aided detection (CAD) system to digitalized mammograms for identifying microcalcifications. Radiol Med (Torino) 101:334-340, 2001.
10. Hwang ES, Kinkel K, Esserman LJ, et al: Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 10:381-388, 2003.
11. Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57:1717-1724, 1986.
12. Silverstein MJ, Barth A, Poller DN, et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31:1425-1427, 1995.
13. Boyages J, Delaney G, Taylor R: Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616-628, 1999.
14. Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G, et al: Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment-the experience of one institute. Am J Clin Oncol 24:531-536, 2001.
15. Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624, 1989.
16. Schwartz GF, Finkel GC, Garcia JC, et al: Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70:2468-2474, 1992.
17. Rubio IT, Mirza N, Sahin AA, et al: Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast. Ann Surg Oncol 7:544-548, 2000.
18. Veronesi U, Banfi A, Del Vecchio M, et al: Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol 22:1085-1089, 1986.
19. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985.
20. Schwartz GF, Solin LJ, Olivotto IA, et al and the Consensus Conference Committee: The Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. Breast J 6:4-13, 2000.
21. Al-Ghazal SK, Sully L, Fallowfield L, et al: The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol 26:17-19, 2000.
22. Singletary SE: Skin-sparing mastectomy with immediate breast reconstruction: the M.D. Anderson Cancer Center experience. Ann Surg Oncol 3:411-416, 1996.
23. Khoo A, Kroll SS, Reece GP, et al: A comparison of resource costs of immediate and delayed breast reconstruction. Plast Reconstr Surg 101:964-968, 1998.
24. Spiegel AJ, Butler CE: Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction. Plast Reconstr Surg 111:706-711, 2003.
25. Rogers NE, Allen RJ: Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg 109:1919-1924, 2002.
26. Petit J, Rietjens M, Garusi C: Breast reconstructive techniques in cancer patients: which ones, when to apply, which immediate and long term risks? Crit Rev Oncol Hematol 38:231-239, 2001.
27. Fisher B, Constantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581-1586, 1993.
28. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998.
29. Julien J-P, Bijker N, Fentiman S, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 355:528-533, 2000.
30. -. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362:95-102, 2003.
31. Silverstein MJ, Lagios MD: Benefits of irradiation for DCIS: a Pyrrhic victory. Lancet 355:510-511, 2000.
32. Bijker N, Peterse JL, Duchateau L, et al: Risk factors for recurrence and metastasis after breast-conserving therapy or ductal carcinoma in situ: analysis of the European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263-2271, 2001.
33. Kestin LL, Goldstein NS, Martinez AA, et al: Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10 year results. Ann Surg 231:235-245, 2000.
34. Cutuli B, Cohen-Solal-le Nir C, De Lafontan R, et al: Ductal carcinoma in situ of the breast; results of conservative and radical treatments in 716 patients. Eur J Cancer 37:2365-2372, 2001.
35. Solin LJ, Kurtz J, Fourquet A, et al: Fifteen year result of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754-763, 1996.
36. Sakorafas GH, Tsiotou AG: Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Treat Rev 26:103-125, 2000.
37. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267-2274, 1996.
38. de Mascarel I, Bonichon F, MacGrogan G, et al: Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations. Breast Cancer Res Treat 61:151-159, 2000.
39. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma of the breast. N Engl J Med 340:1455-1461, 1999.
40. Neuschatz AC, DiPetrillo T, Safaii H, et al: Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer 96:97-104, 2001.
41. Chan KC, Knox WF, Sinha G, et al: Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 91:9-16, 2001.
42. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999.
43. Mokbel K: Recent advances in breast cancer: the 25th Annual San Antonio Breast Cancer Symposium. Curr Med Res Opin 19:143-146, 2003.
44. Fisher B, Land S, Mamounas E, et al: Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28:400-418, 2001.
45. Fisher B, Constantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Natl Cancer Inst 90:1371-1388, 1998.
46. Ragaz J, Coldman A: Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes. J Clin Oncol 16:2018-2024, 1998.
47. Elkak AE, Mokbel K: Pure antiestrogens and breast cancer. Review. Curr Med Res Opin 17:282-289, 2001.
48. Mokbel K: The evolving role of aromatase inhibitors in breast cancer. Review. Int J Clin Oncol 7:279-283, 2002.
49. The ATAC Trialists Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359:2131-2139, 2002.
50. Zhang Z, Yamashita H, Toyama T, et al: Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 74:47-53, 2002.
51. Singh-Ranger G, Mokbel K: The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Review. Eur J Surg Oncol 28:729-737, 2002.
52. Singh-Ranger G, Mokbel K: Current concepts in cyclooxygenase inhibition in breast cancer. Review. J Clin Pharm Ther 27:321-327, 2002.
53. Singh-Ranger G, Mokbel K: The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 29:423-425, 2003.
54. Klauber-DeMore N, Tan LK, Liberman L, et al: Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with micro-invasion? Ann Surg Oncol 7:636-642, 2000.
55. Cox CE, Nguyen K, Gray RJ, et al: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am J Surg 67:513-519, 2001.
56. Intra M, Veronesi P, Mazzarol G, et al: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138(3):309-313, 2003.
57. Mokbel K, Elkak A: The evolving role of mammary ductoscopy. Curr Med Res Opin 18:30-32, 2002.
58. Dooley WC: Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol 9:920-923, 2002.
59. Dowlatshahi K, Francescatti DS, Bloom KJ: Laser therapy for small breast cancers. Am J Surg 184:359-363, 2002.
60. Luzzi V, Holtschlag V, Watson MA: Expression profiling of ductal carcinoma in situ by laser capture microdissection and high density oligonucleotide arrays. Am J Pathol 158:2005-2010, 2001.
61. Wulfkuhle JD, Sgroi DC, Krutzsch H, et al: Proteomics of human breast ductal carcinoma in situ. Cancer Res 62:6740-6749, 2002.
62. Heiken TJ, Farolan M, D'alessandro S, et al: Predicting the biologic behaviour of ductal carcinoma in situ: An analysis of molecular markers. Surgery 30:593-601, 2001.
63. Hoque A, Sneige N, Sahin AA, et al: Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 11:587-590, 2002.